Gilead CFO exercises RSUs, reports tax withholding

Gilead Sciences Chief Financial Officer Andrew D. Dickinson reported routine equity compensation activity.

Rhea-AI Filing Summary

Gilead Sciences Chief Financial Officer Andrew D. Dickinson reported routine equity compensation activity. On June 10, 2026, he exercised restricted stock units covering 2,796 shares of common stock at a conversion price of $0.00 per share.

To cover tax obligations, 1,341 shares of common stock were disposed of as a tax-withholding transaction at $121.48 per share, rather than through an open-market sale. Following these transactions, he holds 174,646 shares of Gilead common stock directly and 27,851 restricted stock units, which vest over a four-year schedule.

Insider Trade Summary

2,796 shares exercised/converted

Exercise 3 txns

Insider Dickinson Andrew D

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Unit	2,796	$0.00	$0.00
Exercise	Common Stock	2,796	$0.00	$0.00
Exercise Price or Tax Liability	Common Stock	1,341	$121.48	$163K

Holdings After Transaction: Restricted Stock Unit — 27,851 contracts (Direct); Common Stock — 174,646 shares (Direct)

Footnotes (2)

1. F1. Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
2. F2. The restricted stock units have a 4-year vesting schedule. 25% vest on the first anniversary of the grant date. The balance will vest 6.25% quarterly thereafter until fully vested.

Key Figures

RSUs exercised: 2,796 shares Tax-withholding shares: 1,341 shares Tax-withholding price: $121.48 per share +3 more

6 metrics

RSUs exercised 2,796 shares Restricted stock units converted to common stock on June 10, 2026

Tax-withholding shares 1,341 shares Shares disposed of to satisfy tax obligations

Tax-withholding price $121.48 per share Value used for tax-withholding disposition

Common shares held after 175,987 shares Direct Gilead common stock ownership after transactions

RSUs outstanding after 27,851 units Restricted stock units remaining after the reported exercise

Exercise price $0.00 per share Conversion price for restricted stock units into common stock

Key Terms

Restricted Stock Unit, tax-withholding disposition, derivative exercise/conversion, 4-year vesting schedule

4 terms

Restricted Stock Unit financial

"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."

A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.

tax-withholding disposition financial

"transaction_action": "tax-withholding disposition""

A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.

derivative exercise/conversion financial

"transaction_action": "derivative exercise/conversion""

4-year vesting schedule financial

"The restricted stock units have a 4-year vesting schedule."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did Gilead (GILD) CFO Andrew Dickinson report?

Gilead CFO Andrew Dickinson reported exercising 2,796 restricted stock units into common shares and a related tax-withholding disposition of 1,341 shares. These actions reflect routine equity compensation events rather than open-market buying or selling of Gilead stock.

How many Gilead (GILD) shares does the CFO hold after this Form 4 filing?

After the reported transactions, Andrew Dickinson directly holds 175,987 shares of Gilead common stock. He also has 27,851 restricted stock units outstanding, which represent additional potential shares that will be delivered as they vest over time.

Was the Gilead (GILD) CFO’s Form 4 transaction an open-market sale?

The Form 4 shows a tax-withholding disposition of 1,341 shares at $121.48 per share, not an open-market sale. These shares were withheld to satisfy tax obligations associated with vesting restricted stock units, a common feature of equity compensation.

What restricted stock unit activity did Gilead (GILD) disclose for its CFO?

The filing shows Andrew Dickinson converted 2,796 restricted stock units into common stock at a $0.00 conversion price. After this derivative exercise, he still holds 27,851 restricted stock units, subject to a four-year vesting schedule with quarterly vesting after the first year.

How do Gilead (GILD) CFO’s restricted stock units vest over time?

Each restricted stock unit represents the right to receive one Gilead common share. The units vest over four years: 25% on the first anniversary of the grant date, with the remaining balance vesting 6.25% quarterly thereafter until fully vested, if service conditions are met.

Does the Gilead (GILD) CFO’s Form 4 indicate net buying or selling of shares?

The Form 4 reflects both acquisition and disposition components, resulting in a neutral net buy/sell position. It combines a derivative exercise of 2,796 restricted stock units with a 1,341-share tax-withholding disposition, typical of routine compensation-related equity vesting.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/11/2026 - 06:32 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Dickinson Andrew D

(Last) (First) (Middle)

GILEAD SCIENCES, INC.

333 LAKESIDE DRIVE

(Street)

FOSTER CITY CALIFORNIA 94404

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
GILEAD SCIENCES, INC. [ GILD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/10/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/10/2026		M		2,796	A	(1)	175,987	D
Common Stock	06/10/2026		F		1,341	D	$121.48	174,646	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit	(1)	06/10/2026		M			2,796	(2)	(2)	Common Stock	2,796	(1)	27,851	D

Explanation of Responses:

1. Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.

2. The restricted stock units have a 4-year vesting schedule. 25% vest on the first anniversary of the grant date. The balance will vest 6.25% quarterly thereafter until fully vested.

Remarks:

	/s/ Amy Kim by Power of Attorney for Andrew D. Dickinson	06/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)